US Stock MarketDetailed Quotes

Prime Medicine (PRME)

Watchlist

2.930
-0.200-6.39%

Close May 15 16:00 ET

2.990
+0.060+2.05%

Post 19:59 ET

529.21MMarket Cap-2.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Prime Medicine (PRME) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

12.58%-42.71M

-32.31%-162.56M

-329.34%-37.26M

-35.22%-35.04M

8.97%-41.41M

27.84%-48.86M

25.72%-122.87M

137.03%16.25M

33.84%-25.91M

-11.44%-45.49M

Net income from continuing operations

5.33%-49.12M

-2.69%-201.14M

-9.00%-46.08M

3.69%-50.58M

4.95%-52.59M

-13.39%-51.89M

1.14%-195.88M

35.60%-42.28M

-3.57%-52.52M

-30.53%-55.33M

Depreciation and amortization

9.18%1.86M

19.47%7.32M

9.26%1.88M

20.73%1.88M

21.20%1.86M

29.28%1.7M

31.70%6.13M

37.69%1.72M

26.05%1.56M

37.57%1.54M

Deferred tax

----

--0

-532.26%-134K

Other non cash items

17.82%2.84M

-21.51%9.7M

17.89%2.6M

-85.16%2.33M

126.29%2.35M

-27.93%2.41M

-3.39%12.36M

-34.05%2.21M

401.59%15.73M

-357.16%-8.93M

Change In working capital

67.33%-2.5M

-117.18%-5.34M

-97.63%1.16M

-82.97%609K

-93.74%548K

74.58%-7.65M

1,074.01%31.08M

238.13%48.86M

49.06%3.58M

256.66%8.75M

-Change in receivables

--0

----

100.22%120K

---103K

---17K

----

---55M

--0

-Change in prepaid assets

254.75%1.22M

128.66%4.55M

140.61%2.6M

118.67%1.3M

424.00%1.44M

71.76%-789K

-67.73%-15.86M

-1,440.48%-6.39M

-85.70%-6.95M

106.85%275K

-Change in payables and accrued expense

80.09%-950K

99.03%-164K

-56.00%1.02M

132.47%1.97M

-84.84%1.62M

80.00%-4.77M

-169.33%-16.91M

-87.34%2.32M

-171.81%-6.06M

382.22%10.69M

-Change in other current liabilities

-200.16%-1.92M

17.01%-5.36M

-276.21%-1.71M

-377.91%-1.6M

35.97%-1.42M

81.57%-638K

47.45%-6.46M

86.75%-454K

85.43%-335K

41.66%-2.21M

-Change in other working capital

40.47%-856K

-106.20%-4.36M

53.33%-751K

---1.18M

---995K

---1.44M

--70.31M

---1.61M

----

Cash from discontinued investing activities

Operating cash flow

12.58%-42.71M

-32.31%-162.56M

-329.34%-37.26M

-35.22%-35.04M

8.97%-41.41M

27.84%-48.86M

25.72%-122.87M

137.03%16.25M

33.84%-25.91M

-11.44%-45.49M

Investing cash flow

Cash flow from continuing investing activities

190.89%43.39M

-258.88%-108.76M

-41.29%28.33M

-282.99%-92.12M

-59.81%2.77M

-28.92%-47.74M

265.86%68.46M

16.88%48.25M

233.29%50.34M

-75.26%6.89M

Net PPE purchase and sale

91.16%-214K

37.88%-4.53M

83.81%-290K

80.66%-247K

17.35%-1.57M

-4.22%-2.42M

16.39%-7.29M

2.66%-1.79M

56.10%-1.28M

3.74%-1.9M

Net investment purchase and sale

196.22%43.61M

-239.44%-104.23M

-42.49%28.62M

-280.52%-91.88M

-50.63%4.34M

-30.58%-45.32M

170.79%74.75M

15.40%49.77M

245.99%50.9M

-70.69%8.8M

Net other investing changes

----

688.24%1M

--276K

----

Cash from discontinued investing activities

Investing cash flow

190.89%43.39M

-258.88%-108.76M

-41.29%28.33M

-282.99%-92.12M

-59.81%2.77M

-28.92%-47.74M

265.86%68.46M

16.88%48.25M

233.29%50.34M

-75.26%6.89M

Financing cash flow

Cash flow from continuing financing activities

-93.45%393K

-22.65%151.51M

56,100.00%562K

275.85%144.75M

462.86%197K

-96.19%6M

29,804.73%195.88M

-99.48%1K

12,011.01%38.51M

-53.33%35K

Net common stock issuance

----

-18.66%138.39M

--10K

263.38%138.38M

--0

--170.14M

--0

--38.08M

--0

Proceeds from stock option exercised by employees

--393K

-94.32%1.12M

55,100.00%552K

-13.66%373K

462.86%197K

--0

2,913.74%19.74M

-99.48%1K

35.85%432K

-53.33%35K

Net other financing activities

----

100.00%12M

--0

--6M

--0

0.00%6M

--6M

--0

Cash from discontinued financing activities

Financing cash flow

-93.45%393K

-22.65%151.51M

56,100.00%562K

275.85%144.75M

462.86%197K

-96.19%6M

29,804.73%195.88M

-99.48%1K

12,011.01%38.51M

-53.33%35K

Net cash flow

Beginning cash position

-60.96%76.72M

256.89%196.54M

-35.56%85.09M

-2.32%67.5M

-1.60%105.94M

256.89%196.54M

-72.62%55.07M

129.81%132.04M

-48.46%69.1M

-26.74%107.66M

Current changes in cash

101.19%1.07M

-184.69%-119.82M

-112.97%-8.36M

-72.05%17.59M

0.31%-38.44M

-272.28%-90.6M

196.87%141.47M

2,804.36%64.5M

182.15%62.94M

-199.28%-38.56M

End cash Position

-26.56%77.8M

-60.96%76.72M

-35.56%85.09M

-2.32%67.5M

-1.60%105.94M

256.89%196.54M

129.81%132.04M

-48.46%69.1M

Free cash flow

16.29%-42.92M

-28.38%-167.1M

-359.76%-37.55M

-29.78%-35.29M

9.30%-42.98M

26.78%-51.28M

25.25%-130.16M

131.63%14.45M

35.38%-27.19M

-10.74%-47.39M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	12.58%-42.71M	-32.31%-162.56M	-329.34%-37.26M	-35.22%-35.04M	8.97%-41.41M	27.84%-48.86M	25.72%-122.87M	137.03%16.25M	33.84%-25.91M	-11.44%-45.49M
Net income from continuing operations	5.33%-49.12M	-2.69%-201.14M	-9.00%-46.08M	3.69%-50.58M	4.95%-52.59M	-13.39%-51.89M	1.14%-195.88M	35.60%-42.28M	-3.57%-52.52M	-30.53%-55.33M
Depreciation and amortization	9.18%1.86M	19.47%7.32M	9.26%1.88M	20.73%1.88M	21.20%1.86M	29.28%1.7M	31.70%6.13M	37.69%1.72M	26.05%1.56M	37.57%1.54M
Deferred tax	----	----	----	----	--0	--0	--0	--0	--0	-532.26%-134K
Other non cash items	17.82%2.84M	-21.51%9.7M	17.89%2.6M	-85.16%2.33M	126.29%2.35M	-27.93%2.41M	-3.39%12.36M	-34.05%2.21M	401.59%15.73M	-357.16%-8.93M
Change In working capital	67.33%-2.5M	-117.18%-5.34M	-97.63%1.16M	-82.97%609K	-93.74%548K	74.58%-7.65M	1,074.01%31.08M	238.13%48.86M	49.06%3.58M	256.66%8.75M
-Change in receivables	--0	----	----	100.22%120K	---103K	---17K	----	----	---55M	--0
-Change in prepaid assets	254.75%1.22M	128.66%4.55M	140.61%2.6M	118.67%1.3M	424.00%1.44M	71.76%-789K	-67.73%-15.86M	-1,440.48%-6.39M	-85.70%-6.95M	106.85%275K
-Change in payables and accrued expense	80.09%-950K	99.03%-164K	-56.00%1.02M	132.47%1.97M	-84.84%1.62M	80.00%-4.77M	-169.33%-16.91M	-87.34%2.32M	-171.81%-6.06M	382.22%10.69M
-Change in other current liabilities	-200.16%-1.92M	17.01%-5.36M	-276.21%-1.71M	-377.91%-1.6M	35.97%-1.42M	81.57%-638K	47.45%-6.46M	86.75%-454K	85.43%-335K	41.66%-2.21M
-Change in other working capital	40.47%-856K	-106.20%-4.36M	53.33%-751K	---1.18M	---995K	---1.44M	--70.31M	---1.61M	----	----
Cash from discontinued investing activities
Operating cash flow	12.58%-42.71M	-32.31%-162.56M	-329.34%-37.26M	-35.22%-35.04M	8.97%-41.41M	27.84%-48.86M	25.72%-122.87M	137.03%16.25M	33.84%-25.91M	-11.44%-45.49M
Investing cash flow
Cash flow from continuing investing activities	190.89%43.39M	-258.88%-108.76M	-41.29%28.33M	-282.99%-92.12M	-59.81%2.77M	-28.92%-47.74M	265.86%68.46M	16.88%48.25M	233.29%50.34M	-75.26%6.89M
Net PPE purchase and sale	91.16%-214K	37.88%-4.53M	83.81%-290K	80.66%-247K	17.35%-1.57M	-4.22%-2.42M	16.39%-7.29M	2.66%-1.79M	56.10%-1.28M	3.74%-1.9M
Net investment purchase and sale	196.22%43.61M	-239.44%-104.23M	-42.49%28.62M	-280.52%-91.88M	-50.63%4.34M	-30.58%-45.32M	170.79%74.75M	15.40%49.77M	245.99%50.9M	-70.69%8.8M
Net other investing changes	----	----	----	----	----	----	688.24%1M	--276K	----	----
Cash from discontinued investing activities
Investing cash flow	190.89%43.39M	-258.88%-108.76M	-41.29%28.33M	-282.99%-92.12M	-59.81%2.77M	-28.92%-47.74M	265.86%68.46M	16.88%48.25M	233.29%50.34M	-75.26%6.89M
Financing cash flow
Cash flow from continuing financing activities	-93.45%393K	-22.65%151.51M	56,100.00%562K	275.85%144.75M	462.86%197K	-96.19%6M	29,804.73%195.88M	-99.48%1K	12,011.01%38.51M	-53.33%35K
Net common stock issuance	----	-18.66%138.39M	--10K	263.38%138.38M	--0	--0	--170.14M	--0	--38.08M	--0
Proceeds from stock option exercised by employees	--393K	-94.32%1.12M	55,100.00%552K	-13.66%373K	462.86%197K	--0	2,913.74%19.74M	-99.48%1K	35.85%432K	-53.33%35K
Net other financing activities	----	100.00%12M	--0	--6M	--0	0.00%6M	--6M	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	-93.45%393K	-22.65%151.51M	56,100.00%562K	275.85%144.75M	462.86%197K	-96.19%6M	29,804.73%195.88M	-99.48%1K	12,011.01%38.51M	-53.33%35K
Net cash flow
Beginning cash position	-60.96%76.72M	256.89%196.54M	-35.56%85.09M	-2.32%67.5M	-1.60%105.94M	256.89%196.54M	-72.62%55.07M	129.81%132.04M	-48.46%69.1M	-26.74%107.66M
Current changes in cash	101.19%1.07M	-184.69%-119.82M	-112.97%-8.36M	-72.05%17.59M	0.31%-38.44M	-272.28%-90.6M	196.87%141.47M	2,804.36%64.5M	182.15%62.94M	-199.28%-38.56M
End cash Position	-26.56%77.8M	-60.96%76.72M	-60.96%76.72M	-35.56%85.09M	-2.32%67.5M	-1.60%105.94M	256.89%196.54M	256.89%196.54M	129.81%132.04M	-48.46%69.1M
Free cash flow	16.29%-42.92M	-28.38%-167.1M	-359.76%-37.55M	-29.78%-35.29M	9.30%-42.98M	26.78%-51.28M	25.25%-130.16M	131.63%14.45M	35.38%-27.19M	-10.74%-47.39M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm